Access: How Do Good Health Technologies Get to Poor People in Poor Countries?

  title={Access: How Do Good Health Technologies Get to Poor People in Poor Countries?},
  author={Laura J Frost and Michael R. Reich},
Many people in developing countries lack access to health technologies even basic ones. [] Key Method The technologies include praziquantel (for the treatment of schistosomiasis) hepatitis B vaccine malaria rapid diagnostic tests vaccine vial monitors for temperature exposure the Norplant implant contraceptive and female condoms. Based on research studies commissioned by the Bill & Melinda Gates Foundation to better understand the development adoption and uptake of health technologies in poor countries the…

Creating access to health technologies in poor countries.

Analysis of six case histories shows that access to health technology in poor countries is difficult to achieve because of multiple obstacles, but it can be created under certain conditions.

PATH: pioneering innovation for global health at the public–private interface

Abstract Seattle-based PATH is one of the world’s largest not-for profit organisations focused on improving health in low-income countries. This article argues the history of this understudied

Adoption of new health products in low and middle income settings: how product development partnerships can support country decision making

When a new health product becomes available, countries have a choice to adopt the product into their national health systems or to pursue an alternate strategy to address the public health problem.

The quest for universal access to effective malaria treatment: how can the AMFm contribute?

The role of the Affordable Medicines Facility-Malaria across and within each dimension is examined and how the AMFm can help to solve access bottlenecks is discussed.

Access to innovative medicines by pharma companies: Sustainable initiatives for global health or useful advertisement?

It is concluded that companies overvalue the term access to medicine, which can generate initiatives focused on advertisements rather than long-term actions and highlights the need for clear global criteria for companies and programmes that want to effectively publicise access to medicines as a social responsibility strategy.

The complexities of simple technologies: re-imagining the role of rapid diagnostic tests in malaria control efforts

Results suggest that while RDTs may be simple to use as stand-alone technological tools, it is not trivial to make them work effectively in a variety of economically pressured health care settings.

A mother’s choice: a qualitative study of mothers’ health seeking behaviour for their children with acute diarrhoea

South African traditional practitioners can be seen as a valuable human resource, especially as they are culturally accepted in their communities, however due to the variability of practices amongst traditional practitioners and some reluctance on the part of modern practitioners regulation and integration may prove complex.

Improving health-care delivery in low-resource settings with nanotechnology

Affordability is only one of the several challenges that will need to be met to translate new ideas into a medical product that addresses a global health need, and some of the other challenges are described that will be faced by nanotechnologists who seek to make an impact in low-resource settings across the globe.